| Tender Brief | Bid To RAs Supply Of Inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Serplulimab 100mg,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,inj Dulaglutide 0 Point 5ml,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,tab Trametinib 0 Point 5mg,inj Human Insulin Lispr Quantity: 50404 |
|---|
